The impact of surgery and mild hyperthermia on tumor response and angioneogenesis of malignant melanoma in a rat perfusion model
/in Hyperthermia, International Publications, Malignant MelanomaClinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination
/in Dendritic Cells, Glioblastoma, International PublicationsTherapeutic cancer vaccines: using unique antigens
/in Dendritic Cells, Hyperthermia, International PublicationsHigh cell surface expression of Newcastle disease virus proteins via replicon vectors demonstrates syncytia forming activity of F and fusion promotion activity of HN molecules
/in International Publications, Newcastle Disease VirusProduction and efficacy of a dendritic cell-based therapeutic vaccine for murine chronic hepatitis B virus carrierer
/in Chronic Virus Hepatitis, International PublicationsProspects for dendritic cell vaccination in persistent infection with hepatitis C virus
/in Chronic Virus Hepatitis, International Publications[Antitumor research on mouse melanoma with combined application of Newcastle disease virus and its HN gene]
/in International Publications, Malignant MelanomaAutologous dendritic cell vaccines for non-small-cell lung cancer
/in Dendritic Cells, International Publications, NSCLCVaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma
/in Dendritic Cells, Glioblastoma, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer